A stagewise response to mitochondrial dysfunction in mitochondrial DNA maintenance disorders
Amy E. VincentiD, Chun CheniD, Tiago M. Bernardino GomesiD, Valeria Di LeoiD, Tuomas LaaloiD, Kamil PabisiD, Rodrick Capaldi, Michael F. Marusich, David McDonaldiD, Andrew J. FilbyiD, Andrew Fuller, Diana Lehmann UrbaniD, Stephan Zierz, Marcus DeschaueriD, Douglass M. TurnbulliD, Amy Katherine ReeveiD, Conor LawlessiD
Abstract
Mitochondrial DNA deletions clonally expand in skeletal muscle of patients with mtDNA maintenance disorders, impairing mitochondrial oxidative phosphorylation dysfunction. Previously we have shown that these mtDNA deletions originally arise and accumulate in the perinuclear mitochondria causing localised mitochondrial dysfunction before spreading through the muscle fibre. We believe that mito-nuclear signalling is a key contributor in this process. To further understand the role of mito-nuclear signalling, we use imaging mass cytometry to characterise the levels of mitochondrial respiratory complexes I-IV and ATP synthase alongside a mitochondrial mass marker, in a cohort of patients with mtDNA maintenance dosirders. We then expanded this panel to include protein markers of key signalling pathways to investigate the cellular response in fibres with different combinations of oxidative phosphorylation dysfunction and in ragged red fibres. We find CI and CIV deficiency to be most common, with a smaller proportion of cells that are also CIII and/or CV deficient. Interestingly, we also note that in cells deficient for one or more complexes, any complexes which are not deficient are commonly upregulated beyond the increase of mitochondrial mass typically observed in ragged red fibres. We further find that oxidative phosphorylation deficient fibres exhibit an increase in abundance of proteins involved in the proteostasis e.g. HSP60 and LONP1, and mitochondrial protein synthesis e.g. PHB1. Our analysis suggests that the cellular response to mitochondrial dysfunction changes depending on the combination of deficient oxidative phosphorylation complexes in each cell.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 5
- FWCI
- 0.56
- Field percentile
- top 45%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single fiber proteomics of respiratory chain defects in mitochondrial disorders
Marta Murgia, Jing Tan, … Thomas Klopstock·bioRxiv·Sep 20, 2018
- Immune cell mitochondrial phenotypes are largely preserved in mitochondrial diseases and do not reflect disease severity
Cynthia C. Liu, Mangesh Kurade, … Martin A. Picard·Neurology GeneticsPeer-reviewed·Jan 2, 2026
- The mitophagy receptor BNIP3L/Nix coordinates nuclear calcium signaling to modulate the muscle phenotype.
J. T. Field, D. Chapman, … J. W. Gordon·bioRxiv·Mar 18, 2023
- Mitochondrial morphology and function in mitochondrial disease
Julie Faitg, Tracey Davey, … Amy E. Vincent·bioRxiv·Dec 20, 2023
- Pathways controlling neurotoxicity and proteostasis in mitochondrial complex I deficiency
Vanitha Nithianandam, Souvarish Sarkar, Mel Β. Feany·Human Molecular GeneticsPeer-reviewed·Jan 26, 2024
- CISD3 is required for Complex I function, mitochondrial integrity, and skeletal muscle maintenance
H.-B. Marjault, O. Karmi, … R. Mittler·bioRxiv·Jun 3, 2023